Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 04:00PM ET
76.85
Dollar change
+2.12
Percentage change
2.84
%
IndexS&P 500 P/E31.47 EPS (ttm)2.44 Insider Own1.36% Shs Outstand125.15M Perf Week3.17%
Market Cap9.58B Forward P/E14.82 EPS next Y5.19 Insider Trans-2.09% Shs Float122.99M Perf Month12.53%
Income314.00M PEG3.73 EPS next Q1.23 Inst Own106.57% Short Float5.25% Perf Quarter12.73%
Sales12.50B P/S0.77 EPS this Y6.10% Inst Trans3.57% Short Ratio3.93 Perf Half Y15.72%
Book/sh27.99 P/B2.75 EPS next Y8.61% ROA3.08% Short Interest6.45M Perf Year7.62%
Cash/sh1.01 P/C76.05 EPS next 5Y8.44% ROE8.78% 52W Range63.67 - 82.63 Perf YTD1.51%
Dividend Est.- P/FCF20.78 EPS past 5Y-1.96% ROI5.54% 52W High-7.00% Beta0.88
Dividend TTM- Quick Ratio0.82 Sales past 5Y5.89% Gross Margin29.62% 52W Low20.70% ATR (14)2.22
Dividend Ex-Date- Current Ratio1.42 EPS Y/Y TTM-27.46% Oper. Margin4.79% RSI (14)61.09 Volatility3.74% 3.17%
Employees25000 Debt/Eq0.85 Sales Y/Y TTM-1.53% Profit Margin2.51% Recom2.64 Target Price74.83
Option/ShortYes / Yes LT Debt/Eq0.62 EPS Q/Q-25.24% Payout0.00% Rel Volume1.19 Prev Close74.73
Sales Surprise-1.90% EPS Surprise4.29% Sales Q/Q0.38% EarningsNov 05 BMO Avg Volume1.64M Price76.85
SMA203.75% SMA506.94% SMA2008.35% Trades Volume1,946,009 Change2.84%
Date Action Analyst Rating Change Price Target Change
Dec-04-24Initiated Mizuho Neutral $75
Jul-22-24Upgrade Robert W. Baird Neutral → Outperform $81 → $92
Feb-26-24Initiated Leerink Partners Market Perform $78
Dec-12-23Upgrade JP Morgan Neutral → Overweight $71 → $82
Nov-10-23Upgrade Stifel Hold → Buy $70
Aug-08-22Upgrade UBS Sell → Neutral $80
Jul-21-22Downgrade Goldman Buy → Neutral $93 → $85
Jun-14-22Downgrade Robert W. Baird Outperform → Neutral $103 → $88
May-13-22Resumed Credit Suisse Outperform $100
Jan-31-22Initiated Morgan Stanley Underweight $67
Dec-05-24 11:30AM
Nov-26-24 09:40AM
Nov-23-24 05:00AM
Nov-21-24 06:30AM
03:59AM
06:30AM Loading…
Nov-20-24 06:30AM
Nov-18-24 04:51PM
01:35PM
Nov-16-24 10:12AM
Nov-06-24 02:15AM
01:46AM
Nov-05-24 12:11PM
09:30AM
07:11AM
07:10AM
06:10AM Loading…
06:10AM
06:00AM
Oct-31-24 01:23PM
09:15AM
Oct-29-24 10:01AM
Oct-24-24 06:30AM
Oct-18-24 12:10PM
Oct-17-24 08:00AM
Oct-08-24 05:33PM
Oct-02-24 04:32PM
Oct-01-24 11:00AM
06:30AM
Sep-30-24 06:30AM
Sep-26-24 03:00PM
06:30AM
07:30AM Loading…
Sep-25-24 07:30AM
06:27AM
Sep-17-24 06:30AM
Sep-12-24 06:30AM
Sep-05-24 11:31AM
07:58AM
Aug-29-24 06:30AM
Aug-23-24 11:35AM
Aug-19-24 09:00AM
08:25AM
Aug-15-24 06:30AM
Aug-12-24 06:30AM
Aug-07-24 06:32AM
03:04AM
Aug-06-24 05:32PM
09:43AM
09:30AM
08:57AM
07:10AM
06:11AM
06:00AM
Aug-05-24 09:16AM
09:05AM
Jul-31-24 06:30AM
Jul-30-24 10:01AM
Jul-26-24 09:50AM
Jul-23-24 09:59AM
Jul-22-24 09:40AM
Jul-18-24 03:33AM
Jul-17-24 05:41PM
Jul-15-24 03:57AM
Jul-12-24 09:33AM
Jul-10-24 04:00PM
Jul-08-24 06:30AM
Jul-05-24 11:30AM
Jul-01-24 06:16AM
Jun-25-24 06:51AM
Jun-12-24 09:40AM
Jun-10-24 07:19AM
07:00AM
Jun-08-24 02:35AM
Jun-06-24 11:31AM
11:25AM
May-27-24 09:40AM
May-21-24 06:30AM
May-20-24 09:50AM
May-17-24 08:10AM
06:30AM
May-16-24 08:41AM
May-15-24 09:06AM
May-13-24 10:40AM
06:30AM
May-08-24 12:54PM
10:23AM
09:40AM
07:40AM
06:19AM
03:28AM
01:14AM
May-07-24 10:55AM
09:30AM
08:58AM
08:06AM
07:32AM
07:10AM
06:38AM
06:09AM
06:00AM
May-02-24 09:15AM
Apr-29-24 06:30AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ettinger Michael SEVP & Chief Operating OfficerNov 18 '24Sale75.0012,240918,00087,706Nov 20 04:15 PM
Ettinger Michael SOfficerNov 18 '24Proposed Sale75.0012,240918,000Nov 18 03:05 PM
McGlynn LoreleiSVP, Chief Human Res. OfficerSep 06 '24Sale69.3021,0351,457,72671,833Sep 09 05:19 PM
McGlynn LoreleiOfficerSep 06 '24Proposed Sale69.9321,0351,470,998Sep 06 11:38 AM
MLOTEK MARK EEVP, Chief Strategic OfficerAug 14 '24Sale69.123,000207,36087,851Aug 15 04:36 PM
MLOTEK MARK EOfficerAug 14 '24Proposed Sale69.123,000207,353Aug 14 12:27 PM
Siegel WalterSr. VP & Chief Legal OfficerJun 06 '24Sale69.474,134287,18939,526Jun 07 04:15 PM
Connett Bradford CCEO, NA Distribution GroupMar 20 '24Sale74.286,430477,62073,108Mar 21 04:18 PM
BRESLAWSKI JAMES PVice Chairman, PresidentMar 18 '24Sale74.372,907216,194209,562Mar 19 04:11 PM
LASKAWY PHILIP ADirectorMar 05 '24Sale76.294,278326,36924,565Mar 06 04:54 PM
KUEHN KURT PDirectorMar 01 '24Sale77.071,582121,92513,598Mar 05 04:52 PM
BRESLAWSKI JAMES PVice Chairman, PresidentMar 04 '24Sale76.502,907222,386212,469Mar 05 04:27 PM
BERGMAN STANLEY MChairman, CEODec 22 '23Sale75.0326,1901,965,036182,595Dec 27 04:10 PM
BERGMAN STANLEY MChairman, CEODec 26 '23Sale75.1413,9621,049,105168,633Dec 27 04:10 PM
BERGMAN STANLEY MChairman, CEODec 22 '23Sale75.0310,914818,877487,270Dec 27 04:10 PM
BERGMAN STANLEY MChairman, CEODec 26 '23Sale75.145,820437,315481,450Dec 27 04:10 PM
Connett Bradford CCEO, NA Distribution GroupDec 21 '23Sale74.0211,238831,83757,831Dec 22 04:02 PM